Dasanat 50 Tablet

Dasanat 50 Tablet Specification

Origin of Medicine
India

Pacakaging (Quantity Per Box)
60 Tablets

Dosage Form
Oral solid tablet

Salt Composition
Dasatinib 50 mg

Packaging Type
Box

Indication
Treatment of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) with Philadelphia chromosome-positive (Ph+)

Life Span
Refer to expiry on packaging

Brand Name
Dasanat 50

Drug Type
Prescription Only

Ingredients
Dasatinib

Physical Form
Tablet

Function
Anti-cancer medication (Tyrosine Kinase Inhibitor)

Recommended For
Adults with certain types of leukemia

Dosage
As prescribed by physician

Dosage Guidelines
Take with or without food as advised by doctor

Suitable For
Adults

Quantity
60 Tablets

Storage Instructions
Store below 30C, protect from light and moisture

Color
White (as per standard tablet appearance)

Warning
Not for use in pregnancy or breastfeeding unless advised by doctor

Administration Route
Oral

Regulatory Status
Approved for therapeutic use under supervision

Side Effects
May include low blood cell counts, bleeding, fluid retention, and others. Refer to leaflet.

Prescription Required
Yes

Patient Counselling Information
Consult oncologist regularly and report any unusual symptoms promptly

Intended Use
To inhibit the growth of cancer cells in specific leukemias

Dasanat 50 Tablet Trade Information

Minimum Order Quantity
10 Pieces

Delivery Time
5-7 Days

About Dasanat 50 Tablet

Unveil the trending and sizzling choice in anti-cancer care-Dasanat 50 Tablet. For a limited time, experience the ravishing efficacy of this wondrous formulation containing Dasatinib 50 mg, designed for excellent treatment of Philadelphia chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL). Dasanat 50, with USFDA approval, assures quality and reliability. Each white tablet is expertly crafted for oral administration, requiring a prescription and supervision. Please consult your healthcare provider regarding possible side effects and comprehensive usage guidance. Exclusively for adults, Dasanat 50 must be stored below 30C.

Targeted Relief for Adults with Ph+ Leukemia

Dasanat 50 Tablet is specifically indicated for adult patients grappling with Philadelphia chromosome-positive CML or ALL. Prescribed strictly by physicians, it delivers powerful results through oral intake, with or without meals as advised. The recommended usage method is oral administration, following the tailored dosage instructions from your healthcare provider. Applied as an antineoplastic, it's designed to support those navigating cancer treatment and must be used under professional medical supervision.

Global and Domestic Market Reach

Dasanat 50 Tablet enjoys robust demand across major export markets due to its stellar certifications, including USFDA approval. The domestic Indian market is equally significant, bolstering extensive expenditure and logistical planning for optimal freight distribution. Estimating delivery timelines depends on market location and regulatory processes. Healthcare providers and distributors rely on its recognized safety and efficacy, making it a preferred choice among leading antineoplastic medications worldwide.

FAQ's of Dasanat 50 Tablet:

Q: How should Dasanat 50 Tablet be administered?

A: Dasanat 50 Tablet should be swallowed whole, with or without food, as directed by your physician. Make sure to follow your doctor's dosage instructions precisely.

Q: What are the main uses of Dasanat 50 Tablet?

A: Dasanat 50 Tablet is primarily used to treat adults with Philadelphia chromosome-positive Chronic Myelogenous Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL).

Q: When is Dasanat 50 Tablet recommended for patients?

A: It is prescribed for adult patients diagnosed with Ph+ CML or ALL upon recommendation by an oncologist or hematologist.

Q: Where should Dasanat 50 Tablet be stored for maximum efficacy?

A: Store the tablets below 30C, away from light and moisture, and always keep them in their original packaging until use.

Q: What side effects may occur during Dasanat 50 treatment?

A: Possible side effects include fluid retention, nausea, fatigue, diarrhea, and lower blood cell counts. Always consult your doctor for a comprehensive overview and management advice.

Q: How can patients benefit from using Dasanat 50 Tablet?

A: Patients benefit from a targeted therapy known for its effectiveness against Ph+ leukemia, supported by rigorous clinical and regulatory validation like USFDA approval.